tropane.svg) | |
| Clinical data | |
|---|---|
| Routes of administration | insufflated |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C15H18FNO2 |
| Molar mass | 263.312 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
3β-(p-Fluorobenzoyloxy)tropane, (8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 4-fluorobenzoic acid ester,4-fluorotropacocaine,3-Pseudotropyl-4-fluorobenzoate,3-pseudotropyl-4-fluorobenzoate,pFBT) is atropane derivative drug which acts as alocal anaesthetic, having around 30% the stimulant potency ofcocaine but around the same potency as a local anaesthetic.[citation needed] It has been investigated as a potentialradiolabelled agent for studyingreceptor binding,[1] but was not adopted for this application. The main application for fluorotropacocaine, however, has been as adesigner druganalogue of cocaine, first detected by theEMCDDA in 2008,[2][3] and subsequently sold as an ingredient of various "bath salt" powder products, usually mixed in combination with other stimulant drugs such ascaffeine,dimethocaine,desoxypipradrol orsubstituted cathinone derivatives.[4]
